Qualia Clinical Services Chooses ALPHADAS(R) for Phase I Clinical Trials



    LONDON, Oct. 21 /CNW/ - Qualia Clinical Services, a highly regarded
division of Holmes Biopharma, selects ALPHADAS(R), Logos Technologies
electronic data capture (EDC) system to streamline and automate clinical
trials in its Phase I clinical facility in Omaha, Nebraska.
    "Automating our recently expanded Phase I facility with ALPHADAS will
enable us to provide our Pharma and Biotech sponsors with top quality, real
time access to critical data while conducting state-of-the-art clinical
trials." - Azhar Kalim, COO of Qualia Clinical Services, Inc.
    "We are committed to helping our clients accelerate their time-to-market.
We decided to re-evaluate the market because our previous EDC vendor was not
meeting our business needs. We chose industry leading ALPHADAS to achieve our
operational goals." - Dr. Sohail Khattak, CEO/President and CSO.
    Logos Technologies has been providing early phase EDC and clinical site
automation tools to the pharmaceutical industry for over 12 years. "We are
delighted to welcome Qualia Clinical Services as a new client and value this
opportunity to facilitate its operational goals," said Giles Wilson, BEng,
co-founder of Logos Technologies. "The partnership will help our mission to
become the world's leading early phase EDC and clinical trial automation
company, assisting organizations to reduce the development time of life-saving
and life-enhancing drugs."
    The rapid success of Qualia's Phase I facility, which opened in the fall
of 2006, necessitated the recent addition of 10,000 square feet. The clinic
now boasts a total of 33,000 square feet, a bed capacity of over 160 beds and
more than 150 professional staff. Additionally, administrative, operational
and recreational areas were completely redesigned to better serve clients and
study participants. Qualia Clinical Services, is changing lives for the better
by providing its partners in the clinical research industry the full
capabilities to complete early and late phase clinical trials. A full service
contract research organization, Qualia has state-of-the-art clinical
operations in Omaha, Nebraska , Toronto, Canada and Kiev, Ukraine. More
information about Qualia can be obtained through its website at
http://www.qualiaclinical.com

    Logos Technologies is a leading provider of world-class integrated
clinical trial solutions to the world's pharmaceutical, biotechnology and
clinical research organisations. ALPHADAS is a clinical study management and
fully mobile early Phase proactive EDC system that has been designed for real
time eSource data collection. The system provides time based data entry at the
bedside, collection and integration of laboratory data, images and scans and
Bar-coded labeling to track samples from draw to dispatch. Logos Technologies
established and proven product ALPHADAS sets the standard in collecting early
Phase clinical trial data. ALPHADAS is fully compliant with industry standards
and guidelines including FDA 21 CFR Part 11. More information about Logos
Technologies can be obtained through its website at
http://www.logostechnologies.com
    For more information contact Angela King, Logos Technologies Ltd,
+44(0)8707-478900
    http://www.logostechnologies.com, http://www.qualiaclinical.com





For further information:

For further information: Angela King, Logos Technologies Ltd,
+44(0)8707-478900, Angela.king@logostechnologies.com; Azhar Kalim, Qualia
Clinical Services, Akalim@qualiaclinical.com

Organization Profile

LOGOS TECHNOLOGIES

More on this organization


Custom Packages

Browse our custom packages or build your own to meet your unique communications needs.

Start today.

CNW Membership

Fill out a CNW membership form or contact us at 1 (877) 269-7890

Learn about CNW services

Request more information about CNW products and services or call us at 1 (877) 269-7890